Predict symptoms and personalize care

Trial ID
NCT03523065
Official Title
The Chinese Parkinson's Disease With GBA Variants Registry
Goal
Predict symptoms and personalize care
Status
RECRUITING
Sponsor
Xiangya Hospital of Central South University
Study Type
OBSERVATIONAL
Enrollment
500 participants
Conditions
Parkinson Disease

Plain-Language Summary

The goal is to learn how variants in the GBA gene affect Parkinson's symptoms, progression, and treatment responses so clinicians can better predict outcomes and personalize care. Instead of testing a drug, researchers are creating a registry that gathers genetic and clinical data and follows about 500 people over time, tracking things like symptom patterns and how patients respond to treatments such as levodopa. Enrollment is for people diagnosed with Parkinson's by standard criteria who have a confirmed GBA variant, the trial lists no age limits and accepts all sexes.

Locations

  • Xiangya Hospital of Central South University, Changsha, Hunan, China

Frequently Asked Questions

What is this trial testing?
This trial is studying an experimental treatment. The goal is to learn how variants in the GBA gene affect Parkinson's symptoms, progression, and treatment responses so clinicians can better predict outcomes and personalize care. Instead of testing a drug, researchers are creating a registry that gathers genetic and clinical data and follows about 500 people over time, tracking things like symptom patterns and how patients respond to treatments such as levodopa. Enrollment is for people diagnosed with Parkinson's by standard criteria who have a confirmed GBA variant, the trial lists no age limits and accepts all sexes.
Who can participate?
Eligibility criteria vary. Check the full listing on ClinicalTrials.gov for detailed inclusion and exclusion criteria.
Where is this trial located?
This trial is recruiting at 1 location.
Does it cost anything to join?
No. There is no cost to participate. Study-related care and treatment are provided at no charge.
How long does the trial last?
This trial is estimated to last approximately 10 years.

View on ClinicalTrials.gov